Company: NUTR
Filing Date: 2025-03-25
Form Type: CORRESP
Source: 0001641172-25-000449
Chunk: 247

Company: NUSATRIP Inc
Filing Date: 2025-03-25
Form: CORRESP
Chunk 247
---
 underwriters and with respect to their unsold allotments or subscriptions.

The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted.

<div align='center'>SUBJECT TO COMPLETION
PRELIMINARY PROSPECTUS DATED JANUARY 15 MARCH 21, 2025

NUSATRIP INCORPORATED

1,066,668 Shares of Common Stock</div>

This prospectus relates to the resale of up to 1,066,668
shares of common stock, $0.0001 par value per share (the “Common Stock”), of NusaTrip Incorporated that may be sold from time
to time by the Selling Stockholders named in this prospectus, which includes:

| ● | 1,066,668 shares of Common Stock held by the Selling Stockholders; and |

We will not receive any proceeds from the sales of
Common Stock by the Selling Stockholders.

No sales of the common stock covered by this prospectus
shall occur until after the closing of our initial public offering. Prior to this offering, there has been no public market for our shares.
We intend to list our shares of Common Stock on the Nasdaq Capital Market under the symbol “NUTR”. Nasdaq might not approve
such application, and if our application is not approved, the Company’s initial public offering cannot be completed and this resale
offering will not proceed.

We are an “emerging growth company”, as
defined in the Jumpstart Our Business Startups Act of 2012, under applicable U.S. federal securities laws, and are eligible for reduced
public company reporting requirements. See “Prospectus Summary — Implications of Being an Emerging Growth Company”
for more information.

On October 18, 2024, we entered into a securities
purchase agreement with the Selling Stockholders. Pursuant to securities purchase agreement, on October 18, 2024, we will issue convertible notes (the “Convertible Notes”) to the Selling Stockholders with an aggregate principal amount of $1,600,002 (the “Convertible Notes Offering”). We are obligated to pay interest to the Selling Stockholders on the outstanding principal amount at the rate of 6.0% per annum